2016 PUBLICATIONS: Department of Cardiovascular Medicine (to-date)

  1. Ahern S, Hopper I and Evans S. The strengths and limitations of clinical quality registries for public reporting of clinician level performance. Med J Aust. 2016.
  2. Alegret JM, Martinez-Micaelo N, La Gerche A, Franco-Bonafonte L, Rubio-Perez F, Calvo N and Montero M. Acute effect of static exercise in patients with aortic regurgitation assessed by cardiovascular magnetic resonance: role of left ventricular remodelling. Eur Radiol. 2016.
  3. Alexis JA, Costello BT, Iles LM, Ellims AH, Hare JL and Taylor AJ. Assessment of the accuracy of common clinical thresholds for cardiac morphology and function by transthoracic echocardiography. J Echocardiography. 2016.
  4. Alhammad NJ, O'Donnell M, O'Donnell D, Mariani JA, Gould PA and McGavigan AD. Cardiac Implantable Electronic Devices and End-of-Life Care: An Australian Perspective. Heart Lung Circ. 2016;25:814-9.
  5. Ariyaratne TV, Yap CH, Ademi Z, Rosenfeldt FL, Duffy SJ, Billah B and Reid CM. A systematic review of cost-effectiveness of percutaneous coronary intervention versus surgery for the treatment of multi-vessel coronary artery disease in the drug-eluting stent era. European Heart Journal – Quality of Care and Clinical Outcomes. 2016.
  6. Asrar Ul Haq M, Tsay IM, Dinh DT, Brennan A, Clark D, Cox N, Harper R, Nadurata V, Andrianopoulos N, Reid C, Duffy SJ, Lefkovits J and van Gaal WJ. Prevalence and outcomes of trans-radial access for percutaneous coronary intervention in contemporary practise. Int J Cardiol. 2016;221:264-8.
  7. Baggish A and La Gerche A. Sports Cardiology: Comprehensive Clinical Care for Athletes and Highly Active Individuals. Cardiol Clin. 2016;34:xi-xii.
  8. Beale A, Gong FF and La Gerche A. Exercise-induced pulmonary oedema in endurance triathletes. Int J Cardiol. 2016;203:980-1.
  9. Beaudry R, Haykowsky MJ, Baggish A and La Gerche A. A Modern Definition of the Athlete's Heart-for Research and the Clinic. Cardiol Clin. 2016;34:507-514.
  10. Cartledge S, Bray JE, Leary M, Stub D and Finn J. A systematic review of basic life support training targeted to family members of high-risk cardiac patients. Resuscitation. 2016;105:70-78.
  11. Cartledge SH, Bray JE, Stub D, Krum H and Finn J. Do Cardiac Rehabilitation Programs Offer Cardiopulmonary Resuscitation Training in Australia and New Zealand? Heart Lung Circ. 2016;25:607-12.
  12. Chen F, Wang I, Graudins L and Hopper I. Is switching anticoagulant brand safe – Coumadin vs Marevan? Australian Medical Student Journal. 2016;7.
  13. Chin KL, Skiba M, Tonkin A, Reid CM, Liew D, Krum H and Hopper I. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice. Heart Fail Rev. 2016.
  14. Claessen G and La Gerche A. Stressing the right ventricular-pulmonary vascular unit: beyond pulmonary vascular resistance. Heart. 2016.
  15. Claessen G and La Gerche A. Exercise-induced cardiac fatigue: the need for speed. J Physiol. 2016;594:2781-2.
  16. Claessen G, La Gerche A, Petit T, Gillijns H, Bogaert J, Claeys M, Dymarkowski S, Claus P, Delcroix M and Heidbuchel H. Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers. J Heart Lung Transplant. 2016.
  17. Claessen G, La Gerche A, Voigt JU, Dymarkowski S, Schnell F, Petit T, Willems R, Claus P, Delcroix M and Heidbuchel H. Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise. JACC Cardiovasc Imaging. 2016;9:532-43.
  18. Costello BT, Nadel J and Taylor AJ. Cardiac sarcoidosis (Review). . Research Reports in Clinical Cardiology 2016.
  19. Crooks N, Chan W, Ivanov J, Horlick EM, Ing D, Overgaard CB and Dzavik V. Adjunctive Bare-Metal Stenting Associated With Improved Outcomes in Patients With Multivessel Disease Treated With Drug-Eluting Stents. Can J Cardiol. 2016;32:1231-1238.
  20. Del Trigo M, Dahou A, Webb JG, Dvir D, Puri R, Abdul-Jawad Altisent O, Campelo-Parada F, Thompson C, Leipsic J, Stub D, DeLarochelliere R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Pasian S, Cote M, Pibarot P and Rodes-Cabau J. Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance. Rev Esp Cardiol (Engl Ed). 2016;69:501-8.
  21. Dvir D, Cheung A, Boone R, Leipsic J, Blanke P, Perlman G, Moss R, Toma M, Stub D, Banai S and Webb J. Transapical mitral valve implantation after unclipping of a MitraClip: a glimpse into the future and treatment considerations in mitral regurgitation. EuroIntervention. 2016;12:e244-9.
  22. Eastwood GM, Schneider AG, Suzuki S, Peck L, Young H, Tanaka A, Martensson J, Warrillow S, McGuinness S, Parke R, Gilder E, McCarthy L, Galt P, Taori G, Eliott S, Lamac T, Bailey M, Harley N, Barge D, Hodgson CL, Morganti-Kossmann MC, Pebay A, Conquest A, Archer JS, Bernard S, Stub D, Hart GK and Bellomo R. Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial). Resuscitation. 2016;104:83-90.
  23. Eikelis N, Hering D, Marusic P, Walton AS, Lambert EA, Sata Y, Krum H, Lambert GW, Esler MD and Schlaich MP. Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation. J Hum Hypertens. 2016.
  24. Elmer J, Torres C, Aufderheide TP, Austin MA, Callaway CW, Golan E, Herren H, Jasti J, Kudenchuk PJ, Scales DC, Stub D, Richardson DK, Zive DM and Resuscitation Outcomes C. Association of early withdrawal of life-sustaining therapy for perceived neurological prognosis with mortality after cardiac arrest. Resuscitation. 2016;102:127-35.
  25. Fan F, Fang L, Moore XL, Xie X, Du XJ, White DA, O'Brien J, Thomson H, Wang J, Schneider HG, Ellims A, Barber TW and Dart AM. Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia. J Am Heart Assoc. 2016;5.
  26. Fan F, Zou Y, Tian H, Zhang Y, Zhang J, Ma X, Meng Y, Yue Y, Liu K and Dart AM. Effects of maternal anxiety and depression during pregnancy in Chinese women on children's heart rate and blood pressure response to stress. J Hum Hypertens. 2016;30:171-6.
  27. Fan F, Zou Y, Zhang Y, Zhang J, Ma X, Liu Y, Geng J, Li J, Liu K and Dart AM. Effects of Maternal Cortisol during Pregnancy on Children's Blood Pressure Responses. Neuroendocrinology. 2016;103:282-90.
  28. Feldman T, Komtebedde J, Burkhoff D, Massaro J, Maurer MS, Leon MB, Kaye D, Silvestry FE, Cleland JG, Kitzman D, Kubo SH, Van Veldhuisen DJ, Kleber F, Trochu JN, Auricchio A, Gustafsson F, Hasenfubeta G, Ponikowski P, Filippatos G, Mauri L and Shah SJ. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I). Circ Heart Fail. 2016;9.
  29. Gao XM, Moore XL, Liu Y, Wang XY, Han LP, Su Y, Tsai A, Xu Q, Zhang M, Lambert GW, Kiriazis H, Gao W, Dart AM and Du XJ. Splenic release of platelets contributes to increased circulating platelet size and inflammation after myocardial infarction. Clin Sci (Lond). 2016;130:1089-104.
  30. Giam B, Chu PY, Kuruppu S, Smith AI, Horlock D, Kiriazis H, Du XJ, Kaye DM and Rajapakse NW. N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure. Physiol Rep. 2016;4.
  31. Giam B, Kaye DM and Rajapakse NW. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome. Heart Lung Circ. 2016;25:874-80.
  32. Giam B, Kuruppu S, Head GA, Kaye DM and Rajapakse NW. Effects of Dietary l-Arginine on Nitric Oxide Bioavailability in Obese Normotensive and Obese Hypertensive Subjects. Nutrients. 2016;8.
  33. Grunau B, Reynolds J, Scheuermeyer F, Stenstom R, Stub D, Pennington S, Cheskes S, Ramanathan K and Christenson J. Relationship between Time-to-ROSC and Survival in Out-of-hospital Cardiac Arrest ECPR Candidates: When is the Best Time to Consider Transport to Hospital? Prehosp Emerg Care. 2016;20:615-22.
  34. Grunau B, Scheuermeyer FX, Stub D, Boone RH, Finkler J, Pennington S, Carriere SA, Cheung A, MacRedmond R, Bashir J and Christenson J. Potential Candidates for a Structured Canadian ECPR Program for Out-of-Hospital Cardiac Arrest. CJEM. 2016:1-8.
  35. Hasenfuss G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der Heyden J, Lang I, Petrie MC, Cleland JG, Leon M, Kaye DM and investigators RL-Hs. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet. 2016;387:1298-304.
  36. Heidbuchel H, Claessen G and La Gerche A. Letter by Heidbuchel et al Regarding Article, "Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study". Circulation. 2016;134:e360-e361.
  37. Hering D, Marusic P, Walton AS, Duval J, Lee R, Sata Y, Krum H, Lambert E, Peter K, Head G, Lambert G, Esler MD and Schlaich MP. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. Int J Cardiol. 2016;202:388-93.
  38. Hobson E, Lannin NA, Taylor A, Farquhar M, Morarty J and Unsworth C. Determining client cognitive status following mild traumatic brain injury. Scand J Occup Ther. 2016;23:138-46.
  39. Hopper I. Chronic heart failure. Australian Prescriber. 2016.
  40. Hopper I, Ahern S, Best RL, McNeil JJ and Cooter RD. The Australian Breast Device Registry –breast device safety transformed. ANZ Journal of Surgery. 2016.
  41. Hopper I, de Silva C, Skiba M, Tonkin A and Krum H. Attitudes of Patients and Prescribing Clinicians to Polypharmacy and Medication Withdrawal in Heart Failure. J Card Fail. 2016;22:743-4.
  42. Hopper I, Kotecha D, Chin KL, Mentz RJ and von Lueder TG. Comorbidities in Heart Failure: Are There Gender Differences? Curr Heart Fail Rep. 2016;13:1-12.
  43. Hopper I, Skiba M, Windebank E, Brack J, Tonkin A and Krum H. Polypharmacy in heart failure - Is reducing medication safe? Int J Cardiol. 2016;214:529-30.
  44. Kaye DM, Nanayakkara S, Vizi D, Byrne M and Mariani JA. Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2016;67:2554-6.
  45. Kaye DM, Vizi D, Nanayakkara S, Byrne M and Mariani J. Phosphodiesterase type iii inhibition improves exercise hemodynamics in patients with HFPEF. . J Am Coll Cardiol. 2016;67:1286.
  46. Kistler PM and Taylor AJ. Myocardial Strain in the Identification of Tachycardia-Induced Cardiomyopathy: Unscrambling the Egg. JACC Cardiovasc Imaging. 2016.
  47. Koshy AN, Nanayakkara S, McGiffin DC, Martin J, Bergin P and Mariani JA. Retained defibrillator leads following orthotopic heart transplantation. Int J Cardiol. 2016;215:87-9.
  48. Kumar S, Chan M, Lee J, Wong M, Matias Y, Morton JB, Spence S, Halloran K, Kistler PM and Kalman JM. Catheter-tissue contact force determines atrial electrogram characteristics before and lesion efficacy after antral pulmonary vein isolation in humans. J Cardiovasc Electrophysiol. 2015.
  49. Kure CE, Rosenfeldt FL, Scholey AB, Pipingas A, Kaye DM, Bergin PJ, Croft KD, Wesnes KA, Myers SP and Stough C. Relationships Among Cognitive Function and Cerebral Blood Flow, Oxidative Stress, and Inflammation in Older Heart Failure Patients. J Card Fail. 2016;22:548-59.
  50. Kurz MC, Prince DK, Christenson J, Carlson J, Stub D, Cheskes S, Lin S, Aziz M, Austin M, Vaillancourt C, Colvin J, Wang HE and Investigators ROC. Association of advanced airway device with chest compression fraction during out-of-hospital cardiopulmonary arrest. Resuscitation. 2016;98:35-40.
  51. La Gerche A. The Potential Cardiotoxic Effects of Exercise. Can J Cardiol. 2016;32:421-8.
  52. La Gerche A and Calkins H. T-wave subtleties in screened athletes: sharpening the lead or whittling the pencil away? Eur Heart J. 2016;37:2528-30.
  53. La Gerche A and Claessen G. Increased Flow, Dam Walls, and Upstream Pressure: The Physiological Challenges and Atrial Consequences of Intense Exercise. JACC Cardiovasc Imaging. 2016.
  54. La Gerche A and McMullen JR. Let's keep running... exercise, basic science and the knowledge gaps. Br J Sports Med. 2016;50:74-6.
  55. Lauck SB, Wood DA, Baumbusch J, Kwon JY, Stub D, Achtem L, Blanke P, Boone RH, Cheung A, Dvir D, Gibson JA, Lee B, Leipsic J, Moss R, Perlman G, Polderman J, Ramanathan K, Ye J and Webb JG. Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay. Circ Cardiovasc Qual Outcomes. 2016;9:312-21.
  56. Lay S, Bernhardt J, West T, Churilov L, Dart A, Hayes K and Cumming TB. Is early rehabilitation a myth? Physical inactivity in the first week after myocardial infarction and stroke. Disabil Rehabil. 2015:1-7.
  57. Ling LH, Kistler PM, Kalman JM, Schilling RJ and Hunter RJ. Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol. 2016;13:131-47.
  58. Marques FZ, Vizi D, Khammy O, Mariani JA and Kaye DM. The transcardiac gradient of cardio-microRNAs in the failing heart. Eur J Heart Fail. 2016;18:1000-8.
  59. Marwick TH and Kaye D. Ventriculoarterial Coupling and the Diagnosis of Early LV Dysfunction. JACC Cardiovasc Imaging. 2016;9:1142-1144.
  60. Marwick TH and Taylor AJ. Contrast-specific Imaging without Contrast: An Echocardiographic Technique for the Detection of Myocardial Scar. JACC Cardiovasc Imaging. 2016.
  61. McAuley SA, Horsburgh JC, Ward GM, La Gerche A, Gooley JL, Jenkins AJ, MacIsaac RJ and O'Neal DN. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia. 2016;59:1636-44.
  62. McLellan AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ and Kistler PM. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. J Cardiovasc Electrophysiol. 2016;27:571-80.
  63. Nehme Z, Stub D, Bernard S, Stephenson M, Bray JE, Cameron P, Meredith IT, Barger B, Ellims AH, Taylor AJ, Kaye DM, Smith K and Investigators A. Effect of supplemental oxygen exposure on myocardial injury in ST-elevation myocardial infarction. Heart. 2016;102:444-51.
  64. Ngu PJ, Butler M, Pham A, Roberts SK and Taylor AJ. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease. Int J Cardiovasc Imaging. 2016;32:629-36.
  65. Prabhu S, Blusztein D, Jackson D, Sharma M, Arunothayaraj S, Stokes MB, Kras A, Yi H, Kong L, Haji K, Peck K, Casan JM and Toogood GD. The Effect of Treatment Delays Associated with Inpatient Inter-hospital Transfer from Peripheral to Tertiary Hospitals for the Surgical Treatment of Cardiology Patients. Heart Lung Circ. 2016;25:75-81.
  66. Prabhu S, Ling LH, Ullah W, Hunter RJ, Schilling RJ, McLellan AJ, Earley MJ, Sporton SC, Voskoboinik A, Blusztein D, Mariani JA, Lee G, Taylor AJ, Kalman JM and Kistler PM. The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study. J Cardiovasc Electrophysiol. 2016;27:281-9.
  67. Prabhu S, Mackin V, McLellan AJ, Phan T, McGlade D, Ling LH, Peck KY, Voskoboinik A, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Lee G, Mariani J, Taylor AJ, Kalman JM and Kistler PM. Determining the Optimal Dose of Adenosine for Unmasking Dormant Pulmonary Vein Conduction Following Atrial Fibrillation Ablation: Electrophysiological and Hemodynamic Assessment. DORMANT-AF study. J Cardiovasc Electrophysiol. 2016.
  68. Prasad A, Ortiz-Lopez C, Khan A, Levin D and Kaye DM. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature. Catheter Cardiovasc Interv. 2016;88:264-73.
  69. Rajapakse NW, Head GA and Kaye DM. Say NO to Obesity-Related Hypertension: Role of the L-Arginine-Nitric Oxide Pathway. Hypertension. 2016;67:813-9.
  70. Ren S, Hure A, Peel R, D'Este C, Abhayaratna W, Tonkin A, Hopper I, Thrift AG, Levi C, Sturm J, Durrheim D, Hung J, Briffa T, Chew DP, Anderson P, Moon L, McEvoy M, Hansbro P, Newby D, Attia J and group As. Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE). Am Heart J. 2016;177:58-65.
  71. Schlaich M, Hering D, Marusic P, Walton A, Lambert E, Krum H, Lambert G, Esler M and Eikelis N. Os 28-02 Renal Denervation Alters Adipokine Levels in Patients with Resistant Hypertension. J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e251.
  72. Schnell F, Claessen G, La Gerche A, Bogaert J, Lentz PA, Claus P, Mabo P, Carre F and Heidbuchel H. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie? Br J Sports Med. 2016;50:111-7.
  73. Segan L, Leet A, Vizi D, Nanayakkara S and Kaye D. Exercise hemodynamics as a predictor of myocardial recovery in LVAD patients. Heart Lung Circ 2016;25:s108.
  74. Sharma D, Kotowycz MA, Sharma V, Choudhury A, Chan W, Freixa X, Dzavik V and Overgaard CB. Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention within 1-year of Coronary Artery Bypass Graft Surgery. . Catheterization and Cardiovascular Interventions. 2016.
  75. Sharma R and Stub D. Controversies in Out of Hospital Cardiac Arrest. Interventional Cardiology Clinics. 2016;5:551-559.
  76. Sharma V, Jolly SS, Hamid T, Sharma D, Chiha J, Chan W, Fuchs F, Bui S, Gao P, Kassam S, Leung RC, Horak D, Romppanen HO, El-Omar M, Chowdhary S, Stankovic G, Kedev S, Rokoss MJ, Sheth T, Dzavik V and Overgaard CB. Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction: insights from the TOTAL trial. Eur Heart J. 2016;37:1891-8.
  77. Siebel AL, Trinh SK, Formosa MF, Mundra PA, Natoli AK, Reddy-Luthmoodoo M, Huynh K, Khan AA, Carey AL, van Hall G, Cobelli C, Dalla-Man C, Otvos JD, Rye KA, Johansson J, Gordon A, Wong NC, Sviridov D, Barter P, Duffy SJ, Meikle PJ and Kingwell BA. Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial. Metabolism. 2016;65:904-14.
  78. Smith AI, Rajapakse NW, Kleifeld O, Lomonte B, Sikanyika NL, Spicer AJ, Hodgson WC, Conroy PJ, Small DH, Kaye DM, Parkington HC, Whisstock JC and Kuruppu S. N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin. Sci Rep. 2016;6:22413.
  79. Smith AI, Rajapakse NW, Kleifeld O, Lomonte B, Sikanyika NL, Spicer AJ, Hodgson WC, Conroy PJ, Small DH, Kaye DM, Parkington HC, Whisstock JC and Kuruppu S. Corrigendum: N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin. Sci Rep. 2016;6:24333.
  80. Stokes MB, Fernando H and Taylor AJ. Cardiogenic shock secondary to methamphetamine induced cardiomyopathy requiring veno-arterial extra-corporeal membrane oxygenation. Int J Cardiol. 2016;207:134-5.
  81. Stokes MB, Taylor AJ, McLean CA, D'Arcy CE and Mariani JA. Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease. Int J Cardiol. 2016;221:14-6.
  82. Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT and Kaye DM. Response to Letter Regarding Article, "Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction". Circulation. 2016;133:e29.
  83. Taylor AJ, Salerno M, Dharmakumar R and Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016;9:67-81.
  84. Trambas C, Pickering JW, Than M, Bain C, Nie L, Paul E, Dart A, Broughton A and Schneider HG. Impact of High-Sensitivity Troponin I Testing with Sex-Specific Cutoffs on the Diagnosis of Acute Myocardial Infarction. Clin Chem. 2016;62:831-8.
  85. Uda Y, Phan TD and Kistler PM. Persistent left atrial thrombus on treatment with rivaroxaban and subsequent resolution after warfarin therapy. Intern Med J. 2016;46:855-6.
  86. Ullah W, Ling LH, Prabhu S, Lee G, Kistler P, Finlay MC, Earley MJ, Sporton S, Bashir Y, Betts TR, Rajappan K, Thomas G, Duncan E, Staniforth A, Mann I, Chow A, Lambiase P, Schilling RJ and Hunter RJ. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death. Europace. 2016;18:679-86.
  87. Vinnakota KC, Cha CY, Rorsman P, Balaban RS, La Gerche A, Wade-Martins R, Beard DA and Jeneson JA. Improving the physiological realism of experimental models. Interface Focus. 2016;6:20150076.
  88. von Lueder TG, Hopper I, Kotecha D and Atar D. In memoriam Henry Krum, 1958-2015. Cardiology. 2016;134:107-8.
  89. Von Lueder TG, Kotecha D, Atar D and Hopper I. Neurohormonal blockade in heart failure: An introduction. Cardiac Failure Reviews. 2016.
  90. Voskoboinik A, Bloom J, Taylor A and Mariani J. Early Implantation of Primary Prevention Implantable Cardioverter Defibrillators for Patients with Newly Diagnosed Severe Nonischemic Cardiomyopathy. Pacing Clin Electrophysiol. 2016;39:992-8.
  91. Voskoboinik A, Ihle JF, Bloom JE and Kaye DM. Methamphetamine-associated cardiomyopathy: patterns and predictors of recovery. Intern Med J. 2016;46:723-7.
  92. Voskoboinik A, McGavigan AD and Mariani JA. Cardiac resynchronisation therapy in 2015: keeping up with the pace. Intern Med J. 2016;46:255-65.
  93. Voskoboinik A, Prabhu S, Ling LH, Kalman JM and Kistler Pm. Alcohol and atrial fibrillation: a sobering review. J Am Coll Cardiol. 2016.
  94. Walters TE, Nisbet A, Morris GM, Tan G, Mearns M, Teo E, Lewis N, Ng A, Gould P, Lee G, Joseph S, Morton JB, Zentner D, Sanders P, Kistler PM and Kalman JM. Progression of atrial remodeling in patients with high-burden atrial fibrillation: Implications for early ablative intervention. Heart Rhythm. 2016;13:331-9.
  95. Wlodarczyk J, Ajani AE, Kemp D, Andrianopoulos N, Brennan AL, Duffy SJ, Clark DJ and Reid CM. Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia. Heart Lung Circ. 2016;25:107-17.
  96. Wright SP, Esfandiari S, Gray T, Fuchs FC, Chelvanathan A, Chan W, Sasson Z, Granton JT, Goodman JM and Mak S. The pulmonary artery wedge pressure response to sustained exercise is time-variant in healthy adults. Heart. 2016;102:438-43.
  97. Yudi MB, Ajani AE, Andrianopoulos N, Duffy SJ, Farouque O, Ramchand J, Gurvitch R, Lefkovits J, Freeman M, Brennan A, Clark DJ, Reid C, Eccleston D and Melbourne Interventional G. Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromes. Coron Artery Dis. 2016;27:344-9.
  98. Yudi MB, Clark DJ, Farouque O, Eccleston D, Andrianopoulos N, Duffy SJ, Brennan A, Lefkovits J, Ramchand J, Yip T, Oqueli E, Reid CM, Ajani AE and Melbourne Interventional G. Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Intern Med J. 2016;46:559-65.
  99. Yudi MB, Ramchand J, Farouque O, Andrianopoulos N, Chan W, Duffy SJ, Lefkovits J, Brennan A, Spencer R, Fernando D, Hiew C, Freeman M, Reid CM, Ajani AE, Clark DJ and Melbourne Interventional G. Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarction. Int J Cardiol. 2016;224:72-78.
  100. Zaman S, Taylor AJ, Stiles M, Chow C and Kovoor P. Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance. Heart Lung Circ. 2016;25:1055-1062.

I am a PATIENT

i-am-a-patient

Consultation in the Heart Centre is only by referral from a Medical Practitioner.

I am a HEALTH PROFESSIONAL

i-am-a-health-professional

Please follow the link to find further information

Your STORIES

our-stories-home

‘This just doesn’t happen to people like me.’  aged 50...

Support US

the-alfred-foundation

Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login